Bio-Techne
TECH
554 hedge funds and large institutions have $8.17B invested in Bio-Techne in 2025 Q2 according to their latest regulatory filings, with 80 funds opening new positions, 219 increasing their positions, 197 reducing their positions, and 100 closing their positions.
174% more call options, than puts
Call options by funds: $13.1M | Put options by funds: $4.78M
11% more repeat investments, than reductions
Existing positions increased: 219 | Existing positions reduced: 197
1.52% less ownership
Funds ownership: 102.72% → 101.2% (-1.5%)
4% less funds holding
Funds holding: 577 → 554 (-23)
14% less capital invested
Capital invested by funds: $9.52B → $8.17B (-$1.34B)
20% less first-time investments, than exits
New positions opened: 80 | Existing positions closed: 100
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$101M |
| 2 |
Millennium Management
New York
|
+$82.4M |
| 3 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$62.2M |
| 4 |
RC
RGM Capital
Naples,
Florida
|
+$59.8M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$50.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$127M |
| 2 |
Select Equity Group
New York
|
-$123M |
| 3 |
BlackRock
New York
|
-$79.1M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$68.8M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$51.4M |
TECH Hedge Fund Activity: Q2 2025 in Review
554 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q2 2025, worth a combined $8.17B — down 14% from $9.52B a quarter earlier.
Sellers outnumbered buyers: 100 funds closed out of TECH and 80 opened new positions — a net loss of 20 holders — while 197 trimmed existing stakes and 219 added.
The largest buyer was Citadel Advisors, adding an estimated $101M. The largest seller was T. Rowe Price Associates, cutting an estimated $127M.
- 554 institutional investors held Bio-Techne (TECH) as of Q2 2025, down from 577 in Q1 2025.
- Funds reported $8.17B of Bio-Techne stock for Q2 2025, down 14% quarter-over-quarter.
- 80 funds opened new Bio-Techne positions in Q2 2025 and 100 closed out, a net change of -20 holders.
- The largest Bio-Techne buyer in Q2 2025 was Citadel Advisors, an estimated $101M added.
- The largest Bio-Techne seller in Q2 2025 was T. Rowe Price Associates, an estimated $127M sold.
Based on aggregated 13F filings for Q2 2025.